The Chronic Obstructive PulmonaryDisease (COPD) Treatment market

Posted by Aarti ghodke on December 7th, 2020

The Chronic Obstructive PulmonaryDisease (COPD) Treatment market size is expected to grow from US$ XXBn in 2019to USD XX Bn by 2026, at a CAGR of 4.1% during the forecast period.

The report includes the analysisof impact of COVID-19 lock-down on the revenue of market leaders, followers,and disrupters. Since lock down was implemented differently in differentregions and countries, impact of same is also different by regions andsegments. The report has covered the current short term and long term impact onthe market, same will help decision makers to prepare the outline for shortterm and long term strategies for companies by region.

Chronic obstructive pulmonarydisease (COPD) is a type of obstructive lung disease characterized by long-termbreathing problems and poor airflow. Tobacco smoking is the most common causeof COPD, with factors such as air pollution and genetics. There are severallifestyle-related factors such as smoking, exposure to biomass fuel, and airpollution, which increase the risk of developing COPD. In addition to tobaccosmoke, there are other factors such as occupational exposure, outdoorpollution. Exposure to second-hand or passive smoking. Smoke from the burningof biomass, respiratory infections, poor nutritional status, chronic asthma,impaired lung growth, poor socio-economic status and dietary factors, whichlead directly or indirectly to COPD.

Increasing preference of pulmonaryroute as an alternate route of drug delivery, rising focus on the developmentof smart/digital inhalers and incidence of respiratory diseases i.e., asthma,and cystic fibrosis is expected to drive the market growth during the forecastperiod. However, emerging markets and growth in online marketing channel offersopportunities for the market. New drug development by market players throughcollaborations and increase in research and development expenditure areanticipated to drive the global market. Propeller Health and Novartis Pharma AGentered into collaboration to develop a custom add-on sensor for the Breezhalerinhaler, a device indicated for COPD treatments.

Rise in number of public andprivate organizations is another major factor propelling the growth of COPDTreatment market. For instance, organizations such as the Asia PacificAssociation of Allergy, Asthma and Clinical Immunology (APAAACI) are engaged inproviding information in clinical and basic research on allergy, asthma, andclinical immunology. Such initiatives are in turn expected to increase themarket in developing regions, thereby boosting overall market growth.

There is a lack of knowledge andawareness about COPD especially in the developing countries due to whichprimary care practitioners (PCPs) and other healthcare providers delay orincorrectly diagnose COPD. Another major factor contributing to the poordiagnosis of COPD is the diagnostic confusion between COPD and asthma. Thus,poor or incorrect diagnosis is a major challenge as it prevents people withCOPD from getting a proper diagnosis which, in turn, has a negative impact onmarket growth.

By drug type, bronchodilators arefurther categorized as Short-Acting Bronchodilators and Long- Acting Bronchodilators.These medications work quickly to relax the muscles around your airways andease symptoms like coughing and shortness of breath. The effects last for about6 to 12 hours.

North America dominates GlobalChronic Obstructive Pulmonary Disease (COPD) Treatment Market because of risein collaborations and high investments in healthcare sector. Globally themarket for COPD is increasing rapidly. The major factor that derives the growthof COPD is the increasing growth in smoking in adults.

The objective of the report is topresent comprehensive analysis of Global Chronic Obstructive Pulmonary Disease(COPD) Treatment Market including all the stakeholders of the industry. Thepast and current status of the industry with forecasted market size and trendsare presented in the report with the analysis of complicated data in simplelanguage. The report covers the all the aspects of industry with dedicatedstudy of key players that includes market leaders, followers and new entrantsby region. PORTER, SVOR, PESTEL analysis with the potential impact ofmicro-economic factors by region on the market have been presented in thereport. External as well as internal factors that are supposed to affect thebusiness positively or negatively have been analyzed, which will give clearfuturistic view of the industry to the decision makers.

The report also helps inunderstanding  dynamics, structure byanalyzing the market segments, and project the Global Chronic ObstructivePulmonary Disease (COPD) Treatment Market size. Clear representation ofcompetitive analysis of key players by Type, price, financial position, productportfolio, growth strategies, and regional presence in the Global ChronicObstructive Pulmonary Disease (COPD) Treatment Market make the report investor’sguide.

 by Drug type

• combination,

• bronchodilators,

• corticosteroids,

• phosphodiesterase type 4inhibitors,

• mucokineticsm

by Distribution channel,

• hospital pharmacies,

• retail pharmacies,

• online pharmacies.

By Region

• Asia-Pacific

• Europe

• North America

• Middle East & Africa

• South America

Key players

• AstraZeneca,

• Boehringer IngelheimPharmaceuticals, Inc.,

• GlaxoSmithKline plc,

• Novartis AG,

• CHIESI Farmaceutici S.p.A.,

• Sunovion Pharmaceuticals, Inc.

• Teva Pharmaceutical IndustriesLtd,

• Mylan N.V.

• Orion Corporation.

• Abbott

• Dr. Reddy's Laboratories Ltd

• F. Hoffmann-La Roche Ltd

• Forest Labs

• GSK

• Galapagos NV

• Merck

• Mundipharma

• Nycomed

• Orexo

For More Information:

https://www.maximizemarketresearch.com/market-report/global-chronic-obstructive-pulmonary-disease-copd-treatment-market/35981/ReportIs Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research providesfree personalized of reports as per your demand. This report can bepersonalized to meet your requirements. Get in touch with us and our sales teamwill guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research providesB2B and B2C research on 20,000 high growth emerging opportunities &technologies as well as threats to the companies across the Healthcare,Pharmaceuticals, Electronics & Communications, Internet of Things, Food andBeverages, Aerospace and Defense and other manufacturing sectors.

Contact info

Name: Lumawant Godage

Organization Address: MAXIMIZEMARKET RESEARCH PVT. LTD.

Email:sales@maximizemarketresearch.com

Address: Omkar Heights, SinhagadRoad, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact:+919607195908     8989132284

Like it? Share it!


Aarti ghodke

About the Author

Aarti ghodke
Joined: August 26th, 2019
Articles Posted: 103

More by this author